Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company
Case Number:
1:18-cv-12029
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 18, 2021
Teva Wants Eli Lilly Sanctioned In Migraine Drug Patent Fight
Teva Pharmaceuticals asked a Massachusetts federal court on Wednesday to sanction Eli Lilly and Co. in their battle over patents tied to a migraine biologic, claiming that the rival failed to obey a court order requiring it to use specific search terms in its collection of electronically stored information.
-
September 28, 2018
Teva Revives Patent Fight After FDA OKs Lilly's Migraine Drug
Hours after a Massachusetts federal judge said Teva Pharmaceuticals couldn't sue Eli Lilly & Co. for infringing patents tied to a migraine biologic because Lilly's version lacked U.S. Food and Drug Administration approval, the agency cleared the drug and Teva sued again.
- ← Previous
- 1
- 2
- Next →